Evolution of Translational Omics:

More documents

Recommendations

Info

SpeakersGil Omenn, IOM Committee ChairProfessor of Computational Medicine & Bioinformatics, InternalMedicine, Human Genetics, and Public HealthUniversity of Michigan, Ann Arbor, MIE. Albert ReeceVice President for Medical Affairs, University of Maryland;John Z. and Akiko K. Bowers Distinguished Professor;Dean, University of Maryland School of Medicine
Disclosure Information:Name of Speaker: Gilbert S. Omenn, MD, PhDI have the following financial relationships to disclose:Employee: University of MichiganBoard of Directors:Amgen Inc.Armune Biosciences Inc.Consultant for (Scientific Advisory Board): Compendia Biosciences, InnocentiveInnovation, Minerva Biotechnology, Galectin Therapeutics, Institute for SystemsBiologySpeaker’s Bureau for: noneGrant/Research support from: National Institutes of HealthStockholder in:Honoraria from:All companies named abovenoneX I will not discuss off label use and/orinvestigational use in my presentation.
Page 1: Evolution of Translational Omics:Le
Page 5 and 6: Origin of the Task for the IOM Comm
Page 7 and 8: IOM Committee Composition20 member
Page 9 and 10: Omics• Encompasses multiple molec
Page 11 and 12: Omics-Based Test DevelopmentFramewo
Page 13 and 14: How are Omics Tests Different?• N
Page 15 and 16: Discovery Phase• Candidate test i
Page 17 and 18: Test Validation Phase
Page 19 and 20: How are Omics Tests Different?• R
Page 21 and 22: Evaluation for Clinical Utility and
Page 23 and 24: Case Studies (see report appendix)
Page 25 and 26: Statistical and Bioinformatics Vali
Page 27: Disclosure Information:Name of Spea
Page 34 and 35: ClinicalTrials.gov ID NCT00636441 N
Page 36 and 37: Importance of:Lessons from the Duke
Page 38 and 39: Recommendation 2: Test Validation
Page 40 and 41: Big PictureRecommendations to ensur
Page 42 and 43: Recommendation 4: Institutions4c: I
Page 44 and 45: Recommendation 6: FDA6a: FDA should
Page 46 and 47: AcknowledgementsStudy Funders:Natio
Page 48 and 49: To download or read the report onli
Page 50 and 51: HER 2 Early single marker test for
Page 52 and 53:
MammaPrint 70 gene microarray expre
Page 54 and 55:
OvaCheck Serum proteomics-based app
Page 56 and 57:
Allomap Blood test; measures expres
show all

Evolution of Translational Omics:

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?